Could CRISPR cure HIV? US biotech Excision raises $60m to find out
pharmaphorum
FEBRUARY 19, 2021
Once someone is infected with HIV it stays with them for life thanks to the retrovirus’s ability to inject its DNA code into the host. Khalili is a named inventor on patents that cover the viral gene editing technology and also holds equity in Excision, where he will act as chief scientific consultant.
Let's personalize your content